News
News
- Myriad’s Polygenic Risk Score Personalizes Risk of Breast Cancer for Woman with a Genetic Mutation in Important Breast Cancer Genes
13:05 - GlobeNewswire - NXT Energy Solutions Inc. Issues Direction to Alberta Green Ventures Limited Partnership Regarding Loan Repayment
02:30 - GlobeNewswire - Rivers Casino Des Plaines Opens New Sports Bar and Expands Gaming Floor
01:41 - GlobeNewswire - Update: Planned Power Shutoffs Are Endangering Californians
01:00 - GlobeNewswire - ShiftPixy, Inc. Reports Fiscal 2019 Results
12/13/2019 / 23:20 - GlobeNewswire - iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
12/13/2019 / 23:00 - GlobeNewswire - Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk
12/13/2019 / 22:49 - GlobeNewswire - ATTO Announces Immediate Support for the 2019 Mac Pro®
12/10/2019 / 20:57 - GlobeNewswire - Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease
12/10/2019 / 13:30 - GlobeNewswire - Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American Society of Hematology Meeting
12/09/2019 / 16:00 - GlobeNewswire
Real-time